2024 David King Community Clinical Scientist Awarded to UH Cancer Center Researcher
April 9, 2024
University of Hawaiʻi Cancer Center’s Christa Braun-Inglis, DNP, APRN, FNP-BC, AOCNP, was awarded the 2024 David King Community Clinical Scientist Award by the Association of Community Cancer Centers (ACCC). Braun-Inglis was recognized for her exceptional dedication to cancer research and education, and her commitment to advancing the goals of cancer prevention, early detection, and quality treatment through her leadership in developing, participating, and evaluating clinical studies.
Braun-Inglis is an oncology researcher who focuses on helping Advanced Practice Providers (APPs) overcome barriers to their participation in clinical trials, which are essential in advancing cancer care. In her research, she has identified several challenges APPs face. She has made commendable progress in expanding their role in National Cancer Institute (NCI) clinical trials, aiming to enhance their engagement and representation. Her clinical trial research includes increasing diversity, optimizing cancer care delivery, and focusing on specific areas such as breast cancer.
"It is such an honor to receive the ACCC 2024 David King Community Clinical Scientist Award!” said Braun-Inglis. “ACCC's dedication to multidisciplinary, team-based care continues to shine by acknowledging the important role advanced practice providers can play in clinical research. Their support for my original APP and clinical trials survey idea paved the way for national policy changes for APP roles in clinical trials, expanded roles for APPs with clinical trials, and a current care delivery research concept, which integrates APPs throughout the NCI Community Oncology Research Program."
Braun-Inglis was honored at the 2024 ACCC Awards Ceremony on March 1st in Washington, DC, during the ACCC's 50th Annual Meeting and Cancer Center Business Summit. The award is named in honor of the late Dr. David K. King, a former president of ACCC, for his lifelong dedication to caring for those with cancer and advocacy for access to quality care.
